WhaleCreep

M28 Capital Management LP 13F holdings, Q2 2026

Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record

M28 Capital Management LP disclosed 9 US equity positions worth $47.2m in its Q2 2026 13F filing. The largest position was WVE at 56.5% of the reported book, followed by IVVD and TGTX. Against the Q1 2026 filing, it opened 0 new positions, added to 0 and reduced 0 among the top 9 holdings.

← Q1 2026

What did M28 Capital Management LP own in Q2 2026? Top 9 positions

#StockSectorWeightValueSharesΔ sharesvs Q1 2026
1 WVE WAVE LIFE SCIENCES LTD Healthcare 56.5%$26.7m4,588,284 0% held
2 IVVD INVIVYD INC Healthcare 17.1%$8.1m9,248,250 0% held
3 TGTX TG THERAPEUTICS INC Healthcare 10.3%$4.9m88,354 0% held
4 ARWR ARROWHEAD PHARMACEUTICALS IN Healthcare 6.4%$3.0m36,851 0% held
5 GUTS FRACTYL HEALTH INC 3.1%$1.5m1,856,117 0% held
6 PROQR THRAPEUTICS N V 2.4%$1.1m599,793 0% held
7 SLN SILENCE THERAPEUTICS PLC 2.4%$1.1m101,203 0% held
8 RCKT ROCKET PHARMACEUTICALS INC Healthcare 1.5%$721.2k210,871 0% held
9 CRIS CURIS INC 0.3%$148.7k284,889 0% held

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.